Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
Ipsen Warns about Brexit Influence on Pharma
France’s Ipsen has become the latest pharma company to warn about the impact of Brexit on the pharma industry and patients’ access to medicines. As Theresa May attempts to drum up support for her B...
Ipsen becomes a member of Biotechnology Innovation Organization
Ipsen announced it has joined the Biotechnology Innovation Organization (BIO), the largest association of biotechnology companies, academic institutions and biotech centers.
Ipsen partnered with MD Anderson Cancer Center to develop new cancer drug
Ipsen, a global biopharmaceutical group, and The University of Texas MD Anderson Cancer Center announced a global licensing and joint development agreement for a pre-clinical oncology drug candidate.
Arix Bioscience and Ipsen start cooperation on innovative therapies
Arix Bioscience, a global healthcare and life science company, and Ipsen, a global specialty-driven biopharmaceutical company announced a strategic agreement to develop and commercialise innovative therapies.
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
R-Pharm – Russian High-Tech Pharmaceutical Enterprise
PIQ-PHARMA Group of Companies
Top 30 pharmaceutical contract manufacturing organisations
GMP Inspection practice: a case for global benchmarking, con...
Merck KGaA will lead Global Oncology Big Data Alliance
Swissmedic Started to Enter GMP Compliance Information into ...
ACG Expands in Brazil
Fedegari, Innovative Way to Thermally Sterilize Hyaluronic A...
Subscribe to Newsletter!
© GMP news